FDA Approves LOSARTAN POTASSIUM — Micro Labs Limited

# FDA Approves Losartan Potassium Generic from Micro Labs Limited Micro Labs Limited has received FDA approval for its generic formulation of losartan potassium, an oral antihypertensive medication, potentially intensifying competition in the competitive blood pressure management market and creating pricing pressure for branded alternatives. The approval of ANDA091541 expands the roster of generic losartan options available to patients and insurers, likely accelerating generic penetration in a therapeutic class valued at billions of dollars annually.